- Successful treatment of metastatic breast tumor using ribociclib in combination with hormonal therapy – case report2023 | Faculty of Medicine in Hradec Králové
- Ribociclib2018 | First Faculty of Medicine
- Ribociclib v léčbě metastatického tumoru prsu2022 | Faculty of Medicine in Hradec Králové
- Case report of a patient on ribociclib, overall survival data from the MONALEESA-2 study2022 | Publication without faculty affiliation
- Ribociclib in the first-line therapy of hormone-dependent generalized breast cancer in a young patient with liver toxicity - case report2020 | First Faculty of Medicine
- Ribociclib shows potential for pharmacokinetic drug-drug interactions being a substrate of ABCB1 and potent inhibitor of ABCB1, ABCG2 and CYP450 isoforms in vitro2018 | Faculty of Pharmacy in Hradec Králové
- Cyclin-dependent kinases - a suitable target in metastatic breast cancer2021 | First Faculty of Medicine
- Therapeutic Drug Monitoring of Protein Kinase Inhibitors in Breast Cancer Patients2021 | First Faculty of Medicine
- Strategies for managing endocrine resistance in advanced hormone receptor-positive and HER2-negative breast cancer2017 | First Faculty of Medicine
- Targeting Pharmacokinetic Drug Resistance in Acute Myeloid Leukemia Cells with CDK4/6 Inhibitors2020 | Faculty of Pharmacy in Hradec Králové, Faculty of Medicine in Hradec Králové